# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001140361-22-046943
Filing Date
2022-12-27
Accepted
2022-12-27 07:00:33
Documents
28
Period of Report
2022-12-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | brhc10045912_8k.htm iXBRL | 8-K | 101188
2 | EXHIBIT 2.1 | brhc10045912_ex2-1.htm | EX-2.1 | 372401
3 | EXHIBIT 2.2 | brhc10045912_ex2-2.htm | EX-2.2 | 883682
4 | EXHIBIT 3.1 | brhc10045912_ex3-1.htm | EX-3.1 | 141141
5 | EXHIBIT 3.2 | brhc10045912_ex3-2.htm | EX-3.2 | 3669
6 | EXHIBIT 10.1 | brhc10045912_ex10-1.htm | EX-10.1 | 88823
7 | EXHIBIT 99.1 | brhc10045912_ex99-1.htm | EX-99.1 | 26290
8 | EXHIBIT 99.2 | brhc10045912_ex99-2.htm | EX-99.2 | 29212
12 |  | brhc10045912_ex99-2slide1.jpg | GRAPHIC | 126183
13 |  | brhc10045912_ex99-2slide2.jpg | GRAPHIC | 429361
14 |  | brhc10045912_ex99-2slide3.jpg | GRAPHIC | 78197
15 |  | brhc10045912_ex99-2slide4.jpg | GRAPHIC | 114632
16 |  | brhc10045912_ex99-2slide5.jpg | GRAPHIC | 111755
17 |  | brhc10045912_ex99-2slide6.jpg | GRAPHIC | 125778
18 |  | brhc10045912_ex99-2slide7.jpg | GRAPHIC | 58550
19 |  | brhc10045912_ex99-2slide8.jpg | GRAPHIC | 108010
20 |  | brhc10045912_ex99-2slide9.jpg | GRAPHIC | 99850
| Complete submission text file | 0001140361-22-046943.txt |  | 3843863

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA | cbio-20221222.xsd | EX-101.SCH | 3908
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | cbio-20221222_lab.xml | EX-101.LAB | 23292
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | cbio-20221222_pre.xml | EX-101.PRE | 16581
22 | EXTRACTED XBRL INSTANCE DOCUMENT | brhc10045912_8k_htm.xml | XML | 4372

Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 221486788
SIC: 2834 Pharmaceutical Preparations